Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Hold
3
﹤0.01% 2248
2025
Q4
$0 Hold
3
﹤0.01% 2254
2025
Q3
$0 Hold
3
﹤0.01% 2275
2025
Q2
$0 Hold
3
﹤0.01% 2196
2025
Q1
$0 Hold
3
﹤0.01% 2203
2024
Q4
$0 Hold
3
﹤0.01% 2218
2024
Q3
$0 Sell
3
-2
-40% -$49 ﹤0.01% 2200
2024
Q2
$0 Buy
5
+1
+25% +$23 ﹤0.01% 2229
2024
Q1
$0 Buy
4
+1
+33% +$33 ﹤0.01% 2222
2023
Q4
$0 Hold
3
﹤0.01% 2130
2023
Q3
$0 Sell
3
-1
-25% -$49 ﹤0.01% 2100
2023
Q2
$0 Hold
4
﹤0.01% 2117
2023
Q1
$0 Sell
4
-4
-50% -$166 ﹤0.01% 2002
2022
Q4
$0 Hold
8
﹤0.01% 2049
2022
Q3
$0 Buy
8
+3
+60% +$137 ﹤0.01% 1970
2022
Q2
$0 Sell
5
-2
-29% -$95 ﹤0.01% 1892
2022
Q1
$0 Sell
7
-1
-13% -$65 ﹤0.01% 2089
2021
Q4
$1K Buy
+8
New +$581 ﹤0.01% 1638

Other funds holding ATRC

Covestor's ATRC Position: Q1 2026 in Review

Covestor held its AtriCure (ATRC) position steady in Q1 2026 at 3 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2248.

Covestor first reported a position in ATRC in Q4 2021 and has held it in 18 quarters since. The position peaked at $1K in Q4 2021. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • Covestor held 3 shares of AtriCure worth $0 as of Q1 2026.
  • Covestor left its AtriCure share count unchanged in Q1 2026.
  • AtriCure made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2248 holding.
  • Covestor first reported a position in AtriCure in Q4 2021 and has held it in 18 quarters since.
  • Covestor's AtriCure position peaked at $1K in Q4 2021.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.